Leave Your Message
-
Phone
-
E-mail
-
Whatsapp
-
Wechat
The global pharmaceutical packaging market is undergoing a massive transformation, with Pharmaceutical PVC Film playing an indispensable role, particularly within the printing and lamination sectors. Polyvinyl chloride (PVC) remains the material of choice for blister packaging, medical pouches, and barrier films due to its exceptional thermoforming properties, cost-effectiveness, and unparalleled clarity. In today's highly regulated medical landscape, the demand for high-grade, non-toxic, and ultra-transparent PVC films has surged exponentially.
Within the printing and lamination industry, the application of pharmaceutical PVC has evolved from simple protective wrapping to highly sophisticated, multi-layered barrier systems. The integration of ALU-PVC (Aluminum-PVC) lamination is a cornerstone of modern drug preservation. This process requires PVC films with precise surface tension and exceptional primer coating compatibility to ensure robust bonding with aluminum foils and barrier substrates like PVDC (Polyvinylidene chloride) or Aclar. Furthermore, the printability of these films is critical. Pharmaceutical packaging mandates strict compliance with traceability, requiring high-definition printing of barcodes, lot numbers, and dosage instructions directly onto the laminated film.
Commercially, the intersection of PVC manufacturing and lamination technology is witnessing a compound annual growth rate (CAGR) driven by the rising consumption of solid oral dosages globally. Manufacturers are now pressured to deliver films that not only meet strict FDA, EMA, and ISO pharmacopeia standards but also withstand the rigorous demands of high-speed rotogravure and flexographic printing presses. The challenge lies in maintaining the film's structural integrity, dimensional stability, and zero-pinhole quality under the intense heat and tension of industrial lamination rollers.
To meet these exacting standards, modern factories are deploying AI-driven quality control systems. Machine vision algorithms now scan PVC webs in real-time, detecting microscopic gels, black spots, or gauge variations that could compromise the lamination bond or printing registration. This technological leap ensures that every roll of pharmaceutical PVC film delivered to converters guarantees maximum yield and uncompromising patient safety.
Jiangsu Dahai Plastics Co., Ltd. was founded in 1996, is a professional production of various types of PVC film and printing PVC film technology of private enterprises. We mainly produce super transparent film, ordinary transparent film, toy film, bath film, raincoat film, electrical tape film, cold film, non-stick film, decorative film, PEVA film, particles, tablecloth, shower curtain, urine bag.
The company has more than 20 production lines, more than 450 employees, of which 30% are technical management personnel, and has a sound management system. Covers an area of more than 120,000 square meters, annual output of more than 100,000 tons, annual sales of more than 1 billion. The company continues to introduce advanced production equipment and technology. The product quality reaches the international standard, the company's products not only sell well in the domestic market, but also exported to South America, Southeast Asia, Africa and other places.
The total registered capital of several projects under the company group is 40 million dollar, total assets reach 140 million dollar, floor area is more than 120000sqm, with 20 imported environmental protection production lines, with an annual production capacity of 150,000 tons. In year 2018, we achieved sales of 180 million dollar, of which exports earned 10 million US dollars. The products are sold to more than 400 cities in 12 provinces and regions across the country, the market share ranks first among private enterprises in the province, and the products are exported to more than 10 countries and regions. In view of the market development trend and the future development of the company, it is proposed to build an intelligent manufacturing project of new medical materials.
In the pharmaceutical packaging sector, the visual clarity and ink adhesion of PVC films are non-negotiable. Pharmaceutical PVC films must undergo rigorous surface treatment to achieve the optimal dyne level (surface tension), ensuring that UV-curable and solvent-based inks adhere flawlessly. During high-speed rotogravure printing, the film must exhibit exceptional dimensional stability to prevent web elongation, which can lead to catastrophic color registration errors. Advanced calendering techniques used by industry leaders ensure that the PVC film possesses a perfectly uniform gauge profile, mitigating the risk of dot gain or missing print areas, which is vital for the legibility of microscopic dosage instructions and anti-counterfeiting micro-text.
The lamination industry relies heavily on Pharmaceutical PVC as a base web for creating complex barrier structures. When laminated with PE (Polyethylene), PVDC, or Aluminum foil, the PVC provides the structural rigidity and thermoformability required for blister cavities. The lamination process—whether dry, wet, or solventless—demands a PVC substrate free of plasticizer migration and surface contaminants. Specialized adhesive systems are deployed to bond the PVC to the barrier layers. If the PVC film has inconsistent surface energy, delamination can occur during the thermoforming process, compromising the Moisture Vapor Transmission Rate (MVTR) and Oxygen Transmission Rate (OTR), ultimately leading to drug degradation.
As the printing and lamination industry evolves, the production of Pharmaceutical PVC Film is experiencing a paradigm shift driven by Industry 4.0 and Artificial Intelligence. Historically, quality control in PVC calendering relied on periodic manual sampling. Today, the integration of AI-powered inline monitoring systems represents a massive leap forward. Smart sensors equipped with machine learning algorithms continuously scan the PVC web for optical distortions, gauge variations down to the micron level, and thermal inconsistencies during the extrusion and cooling phases. This predictive maintenance and real-time adjustment capability drastically reduce material waste and ensure a 99.9% defect-free yield, which is crucial for high-stakes medical lamination.
Furthermore, the industry is navigating the complex balance between strict pharmaceutical regulations and global sustainability goals. While alternative materials exist, PVC remains dominant due to its unmatched performance-to-cost ratio and extensive FDA/EMA approvals. The current trend focuses on developing low-toxicity, phthalate-free PVC formulations. Innovations in bio-based plasticizers and advanced compounding techniques are yielding PVC films that maintain their essential properties—flexibility, clarity, and printability—while minimizing environmental impact. In the lamination sector, there is a strong push towards mono-material structures to enhance recyclability, pushing PVC manufacturers to engineer films that can offer enhanced barrier properties without relying on multi-polymer lamination, thus simplifying the recycling stream.
We possess laboratories accredited by China National Commission for Conformity Assessment (CNAS), which are equipped with many kinds of world advanced experimental equipment and physical and chemical testing-analysis instruments. In every experiment, in every test, even the slightest difference can be detected by our machines, which greatly guarantees the quality of our products.
DAHAI continues to invest resources, and we will work with university teams to develop products. Our technical department is constantly learning new technologies and combining them with our own situation, through which our ability to innovate is keeping improving.
We import all kinds of testing machines, such as universal testing machines, Agilent GC analyzers, gloss meters and cold-tolerance testing machines. Besides, we establish good cooperation with professional testing companies to meet customer's requirements. All of our products can meet the requirements of EN-71, ASTM-F-963, Model Toxics in Packaging Legislation (CONEG) and RoHS.
Make green materials, create a good and healthy life!
To become the domestic polymer material application industry leader, to build a world-class brand!
Independent innovation intelligent future! Team style: people-oriented safety first! Integrity, pragmatic, efficient, win-win!
Tongzhou Huaming Plastic Co., Ltd. was established.
Changed to Jiangsu Dahai Plastics Co., LTD.
Nantong Runyang Plastic Co., Ltd. was established.
Dahai Real Estate Development Co., Ltd. was established.
Field E-commerce company is established.
Jiangyin Zhonglian Real Estate company was established.
Jiangyin Huayue Real Estate Development Co., Ltd. established.
Jiangsu Houbang Industrial Co., LTD.
Dahai Plastic assists customers around the world in developing and manufacturing products for packaging, medical supplies, and building materials. In the highly specialized field of Pharmaceutical PVC Film for the printing and lamination industry, off-the-shelf solutions rarely suffice. Pharmaceutical companies and packaging converters require bespoke formulations tailored to specific drug stability profiles and machinery tolerances. Our OEM and ODM services are designed to bridge the gap between conceptual packaging engineering and mass commercial production.
When a client approaches us for a custom lamination film, our R&D team initiates a comprehensive material science analysis. We evaluate the required barrier properties, the specific type of printing ink (solvent, water-based, or UV) to be used, and the lamination adhesive chemistry. By adjusting the plasticizer ratios, stabilizers, and surface treatments, we engineer a PVC film that guarantees flawless machinability. Our rapid prototyping capabilities allow clients to run pilot tests on their own rotogravure or flexographic lines, ensuring that the film meets all coefficient of friction (COF) and tensile strength requirements before full-scale manufacturing commences. This collaborative, data-driven approach ensures complete realization from concept to market.
Our dedicated sales and technical teams engage closely with customers to gather detailed specifications, discuss project goals, and identify any unique challenges.
Once the needs are confirmed, we move into the product proofing phase. During this stage, we create prototypes or samples based on the agreed-upon specifications.
After thorough evaluation and refinement, we finalize the sample that both parties agree upon. The confirmed sample serves as the benchmark for all subsequent production runs.
Our make-to-order approach allows us to tailor our production processes to meet individual client needs, leveraging our flexible manufacturing capabilities.
Upon completion of production, each item undergoes a comprehensive finished inspection. Our quality assurance team employs advanced testing methods.
We actively seek feedback to continuously improve our services and adapt to evolving market demands. Through ongoing partnerships, we aim to be more than just a supplier.
